MarginsXMarginsX
Home › Markets › AIBT

Aibotics Therapies, Inc. (AIBT)

AIBT is quoted over the counter, not listed on an exchange. Aibotics Therapies, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close · November 16, 2026
$0.0035
+12.9% on the day
1-year return
+80.4%
Market cap
$3.0M
Nano cap. From the Nov 16, 2026 close × 850.2M shares (10-Q cover page, Aug 19, 2026)
P/E and P/S
Net loss over the period · No revenue
On trailing twelve months to June 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-16.

Profile

FieldValue
TickerAIBT, quoted over the counter
SEC CIK0001763329
OTC Markets tierOTCID (price source, 2026-11-13)
SEC industry codeMedicinal Chemicals & Botanical Products
Business addressHeyburn, ID
Incorporated inNV

Warning signs

Cash runway
8.0 months
$233K cash at June 30, 2026
Share count, 1 year
+343.0%
2025-08-19 to 2026-08-19 · +5607.0% over 3 years
Going-concern doubt
Yes
10-Q filed August 19, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions raise substantial doubt about the Company's ability to continue as a going concern for a period of time within one year after that date that the consolidated financial statements are issued."
10-Q 2026-08-19
Cash and burn$233K cash; operating cash flow -$87K a quarter.Report 2026-06-30
Shares outstanding850,165,334 (2026-08-19); 191,904,437 a year earlier; 14,896,791 three years earlier.Cover page 2026-08-19
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorFruci & Associates II, PLLC, Spokane, Washington, United StatesPCAOB Form AP 2026-04-22
Late filings, 12 months3 NT noticesNT 10-Q 2026-08-14
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$0-$537K-$47K$233K$2.4M$010-Q 2026-08-19
Q1 2026
2026-03-31
$0-$418K-$36K$289K$2.6M$010-Q 2026-06-09
Q4 2025
2025-12-31
$0-$608K-$87K$256K$2.4M$2K10-K 2026-04-15
Q3 2025
2025-09-30
$0-$530K-$179K$230K$2.8M$2K10-Q 2025-11-19
Q2 2025
2025-06-30
$0-$486K-$165K$242K$2.9M$2K10-Q 2026-08-19
Q1 2025
2025-03-31
$2K-$591K-$28K$157K$2.4M$2K10-Q 2026-06-09
Q4 2024
2024-12-31
$0-$492K-$17K$185K$2.4M$010-K 2026-04-15
Q3 2024
2024-09-30
$0-$460K-$78K$202K$2.4MNeeds four quarters10-Q 2025-11-19

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document253G22025-07-03
Latest annual report10-K2026-04-15
Latest quarterly / interim10-Q2026-08-19
Latest current report8-K2026-10-16

Source: SEC EDGAR submissions feed, 111 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier